nodes	percent_of_prediction	percent_of_DWPC	metapath
Famotidine—SLC47A1—Metformin—metabolic syndrome X	0.733	0.764	CbGbCtD
Famotidine—SLC22A2—Metformin—metabolic syndrome X	0.227	0.236	CbGbCtD
Famotidine—Appetite absent—Metformin—metabolic syndrome X	0.00377	0.103	CcSEcCtD
Famotidine—Ear pain—Metformin—metabolic syndrome X	0.00159	0.0434	CcSEcCtD
Famotidine—Nasal congestion—Metformin—metabolic syndrome X	0.00149	0.0407	CcSEcCtD
Famotidine—Pain in extremity—Metformin—metabolic syndrome X	0.00136	0.0371	CcSEcCtD
Famotidine—Migraine—Metformin—metabolic syndrome X	0.00134	0.0365	CcSEcCtD
Famotidine—Cramp muscle—Metformin—metabolic syndrome X	0.00122	0.0334	CcSEcCtD
Famotidine—Influenza—Metformin—metabolic syndrome X	0.00118	0.032	CcSEcCtD
Famotidine—Abdominal discomfort—Metformin—metabolic syndrome X	0.00113	0.0307	CcSEcCtD
Famotidine—Neutropenia—Metformin—metabolic syndrome X	0.0011	0.03	CcSEcCtD
Famotidine—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00109	0.0298	CcSEcCtD
Famotidine—Bradycardia—Metformin—metabolic syndrome X	0.000958	0.0261	CcSEcCtD
Famotidine—Hepatitis—Metformin—metabolic syndrome X	0.000941	0.0256	CcSEcCtD
Famotidine—Flushing—Metformin—metabolic syndrome X	0.000873	0.0238	CcSEcCtD
Famotidine—Dysgeusia—Metformin—metabolic syndrome X	0.000802	0.0219	CcSEcCtD
Famotidine—Muscle spasms—Metformin—metabolic syndrome X	0.000787	0.0215	CcSEcCtD
Famotidine—Syncope—Metformin—metabolic syndrome X	0.000734	0.02	CcSEcCtD
Famotidine—Palpitations—Metformin—metabolic syndrome X	0.000724	0.0197	CcSEcCtD
Famotidine—Loss of consciousness—Metformin—metabolic syndrome X	0.00072	0.0196	CcSEcCtD
Famotidine—Chest pain—Metformin—metabolic syndrome X	0.000697	0.019	CcSEcCtD
Famotidine—Myalgia—Metformin—metabolic syndrome X	0.000697	0.019	CcSEcCtD
Famotidine—Oedema—Metformin—metabolic syndrome X	0.000668	0.0182	CcSEcCtD
Famotidine—Infection—Metformin—metabolic syndrome X	0.000664	0.0181	CcSEcCtD
Famotidine—Shock—Metformin—metabolic syndrome X	0.000658	0.0179	CcSEcCtD
Famotidine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000654	0.0178	CcSEcCtD
Famotidine—Anorexia—Metformin—metabolic syndrome X	0.000637	0.0174	CcSEcCtD
Famotidine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000609	0.0166	CcSEcCtD
Famotidine—Paraesthesia—Metformin—metabolic syndrome X	0.0006	0.0164	CcSEcCtD
Famotidine—Somnolence—Metformin—metabolic syndrome X	0.000594	0.0162	CcSEcCtD
Famotidine—Dyspepsia—Metformin—metabolic syndrome X	0.000588	0.016	CcSEcCtD
Famotidine—Decreased appetite—Metformin—metabolic syndrome X	0.000581	0.0158	CcSEcCtD
Famotidine—Fatigue—Metformin—metabolic syndrome X	0.000576	0.0157	CcSEcCtD
Famotidine—Constipation—Metformin—metabolic syndrome X	0.000572	0.0156	CcSEcCtD
Famotidine—Feeling abnormal—Metformin—metabolic syndrome X	0.000551	0.015	CcSEcCtD
Famotidine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000547	0.0149	CcSEcCtD
Famotidine—Urticaria—Metformin—metabolic syndrome X	0.000531	0.0145	CcSEcCtD
Famotidine—Abdominal pain—Metformin—metabolic syndrome X	0.000528	0.0144	CcSEcCtD
Famotidine—Asthenia—Metformin—metabolic syndrome X	0.00048	0.0131	CcSEcCtD
Famotidine—Pruritus—Metformin—metabolic syndrome X	0.000473	0.0129	CcSEcCtD
Famotidine—Diarrhoea—Metformin—metabolic syndrome X	0.000457	0.0125	CcSEcCtD
Famotidine—Dizziness—Metformin—metabolic syndrome X	0.000442	0.012	CcSEcCtD
Famotidine—Vomiting—Metformin—metabolic syndrome X	0.000425	0.0116	CcSEcCtD
Famotidine—Rash—Metformin—metabolic syndrome X	0.000421	0.0115	CcSEcCtD
Famotidine—Dermatitis—Metformin—metabolic syndrome X	0.000421	0.0115	CcSEcCtD
Famotidine—Headache—Metformin—metabolic syndrome X	0.000419	0.0114	CcSEcCtD
Famotidine—Nausea—Metformin—metabolic syndrome X	0.000397	0.0108	CcSEcCtD
Famotidine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.000355	0.0991	CbGpPWpGaD
Famotidine—CYP2C19—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.000184	0.0514	CbGpPWpGaD
Famotidine—HRH2—Monoamine GPCRs—HTR2C—metabolic syndrome X	0.000166	0.0463	CbGpPWpGaD
Famotidine—HRH2—Amine ligand-binding receptors—HTR2C—metabolic syndrome X	0.00014	0.0389	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	0.000112	0.0313	CbGpPWpGaD
Famotidine—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—metabolic syndrome X	0.000105	0.0292	CbGpPWpGaD
Famotidine—CYP2C19—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	8.89e-05	0.0248	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	8.2e-05	0.0229	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	7.7e-05	0.0215	CbGpPWpGaD
Famotidine—CYP2C19—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	6.45e-05	0.018	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	6.12e-05	0.0171	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	5.71e-05	0.0159	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	5.3e-05	0.0148	CbGpPWpGaD
Famotidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—metabolic syndrome X	4.94e-05	0.0138	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	4.76e-05	0.0133	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	4.12e-05	0.0115	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	3.92e-05	0.0109	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—G6PC2—metabolic syndrome X	3.69e-05	0.0103	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	3.63e-05	0.0101	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	3.53e-05	0.00983	CbGpPWpGaD
Famotidine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—metabolic syndrome X	3.43e-05	0.00957	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—FMO3—metabolic syndrome X	3.43e-05	0.00955	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—FMO3—metabolic syndrome X	3.38e-05	0.00942	CbGpPWpGaD
Famotidine—CYP2C19—Melatonin metabolism and effects—APOE—metabolic syndrome X	3.32e-05	0.00926	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	3.21e-05	0.00894	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—GGT1—metabolic syndrome X	3.16e-05	0.00882	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	3.11e-05	0.00867	CbGpPWpGaD
Famotidine—CYP2C19—Metapathway biotransformation—EPHX2—metabolic syndrome X	3.01e-05	0.0084	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	3e-05	0.00837	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	2.88e-05	0.00804	CbGpPWpGaD
Famotidine—HRH2—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	2.88e-05	0.00803	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	2.75e-05	0.00766	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	2.69e-05	0.0075	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—MTNR1B—metabolic syndrome X	2.69e-05	0.00749	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	2.61e-05	0.00728	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	2.6e-05	0.00726	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—GCKR—metabolic syndrome X	2.53e-05	0.00704	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	2.47e-05	0.00688	CbGpPWpGaD
Famotidine—SLC47A1—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	2.45e-05	0.00684	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	2.42e-05	0.00674	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	2.24e-05	0.00625	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—HTR2C—metabolic syndrome X	2.09e-05	0.00583	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—GCK—metabolic syndrome X	2.01e-05	0.00559	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	1.99e-05	0.00554	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—GHRL—metabolic syndrome X	1.98e-05	0.00553	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	1.91e-05	0.00533	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CNR1—metabolic syndrome X	1.88e-05	0.00524	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	1.87e-05	0.00522	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	1.84e-05	0.00514	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.68e-05	0.00467	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	1.6e-05	0.00446	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.57e-05	0.00438	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—SLC2A4—metabolic syndrome X	1.56e-05	0.00435	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—MTNR1B—metabolic syndrome X	1.52e-05	0.00423	CbGpPWpGaD
Famotidine—CYP2C19—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	1.47e-05	0.0041	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—GCK—metabolic syndrome X	1.47e-05	0.00409	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCL5—metabolic syndrome X	1.46e-05	0.00406	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—CETP—metabolic syndrome X	1.41e-05	0.00394	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—MTNR1B—metabolic syndrome X	1.38e-05	0.00384	CbGpPWpGaD
Famotidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	1.32e-05	0.00367	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	1.28e-05	0.00358	CbGpPWpGaD
Famotidine—SLC47A1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.25e-05	0.00347	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—AGT—metabolic syndrome X	1.22e-05	0.00339	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—HTR2C—metabolic syndrome X	1.18e-05	0.0033	CbGpPWpGaD
Famotidine—CYP2C19—Biological oxidations—GGT1—metabolic syndrome X	1.18e-05	0.00328	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	1.17e-05	0.00327	CbGpPWpGaD
Famotidine—SLC22A8—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	1.16e-05	0.00322	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	1.14e-05	0.00318	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—GHRL—metabolic syndrome X	1.12e-05	0.00312	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—HTR2C—metabolic syndrome X	1.07e-05	0.00299	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CNR1—metabolic syndrome X	1.06e-05	0.00296	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FMO3—metabolic syndrome X	1.05e-05	0.00292	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—GCK—metabolic syndrome X	1.02e-05	0.00284	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—GHRL—metabolic syndrome X	1.02e-05	0.00284	CbGpPWpGaD
Famotidine—HRH2—GPCR ligand binding—CCL2—metabolic syndrome X	1e-05	0.0028	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—CETP—metabolic syndrome X	9.84e-06	0.00274	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CNR1—metabolic syndrome X	9.64e-06	0.00269	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	9.37e-06	0.00261	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOB—metabolic syndrome X	9.37e-06	0.00261	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—MLXIPL—metabolic syndrome X	9.33e-06	0.0026	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—EPHX2—metabolic syndrome X	9.33e-06	0.0026	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HDAC3—metabolic syndrome X	9.11e-06	0.00254	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	8.89e-06	0.00248	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—G6PC2—metabolic syndrome X	8.77e-06	0.00245	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—CCL5—metabolic syndrome X	8.23e-06	0.00229	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—MTNR1B—metabolic syndrome X	8.14e-06	0.00227	CbGpPWpGaD
Famotidine—SLC22A2—SLC-mediated transmembrane transport—ALB—metabolic syndrome X	8.04e-06	0.00224	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TRIB3—metabolic syndrome X	7.93e-06	0.00221	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—RBP4—metabolic syndrome X	7.93e-06	0.00221	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	7.93e-06	0.00221	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	7.9e-06	0.0022	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	7.73e-06	0.00216	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	7.56e-06	0.00211	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL5—metabolic syndrome X	7.47e-06	0.00208	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—FABP4—metabolic syndrome X	7.46e-06	0.00208	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—PLA2G4A—metabolic syndrome X	7.44e-06	0.00207	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	7.41e-06	0.00207	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	7.32e-06	0.00204	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	7.24e-06	0.00202	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HSD11B1—metabolic syndrome X	7.07e-06	0.00197	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOC3—metabolic syndrome X	7.03e-06	0.00196	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AGT—metabolic syndrome X	6.88e-06	0.00192	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	6.73e-06	0.00188	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOB—metabolic syndrome X	6.52e-06	0.00182	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—HTR2C—metabolic syndrome X	6.34e-06	0.00177	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—G6PD—metabolic syndrome X	6.3e-06	0.00176	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AGT—metabolic syndrome X	6.25e-06	0.00174	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HDAC3—metabolic syndrome X	6.15e-06	0.00171	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CYBA—metabolic syndrome X	6.14e-06	0.00171	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—GHRL—metabolic syndrome X	6.01e-06	0.00168	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCKR—metabolic syndrome X	6.01e-06	0.00168	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPA—metabolic syndrome X	6.01e-06	0.00168	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	6e-06	0.00167	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	5.97e-06	0.00166	CbGpPWpGaD
Famotidine—SLC22A8—Transmembrane transport of small molecules—ALB—metabolic syndrome X	5.87e-06	0.00164	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FMO3—metabolic syndrome X	5.86e-06	0.00163	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G6—metabolic syndrome X	5.82e-06	0.00162	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	5.79e-06	0.00161	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA5—metabolic syndrome X	5.76e-06	0.00161	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CNR1—metabolic syndrome X	5.69e-06	0.00159	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	5.55e-06	0.00155	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	5.5e-06	0.00153	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	5.38e-06	0.0015	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—TRIB3—metabolic syndrome X	5.36e-06	0.00149	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	5.24e-06	0.00146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—MLXIPL—metabolic syndrome X	5.22e-06	0.00146	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—EPHX2—metabolic syndrome X	5.22e-06	0.00146	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	5.16e-06	0.00144	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—CCL2—metabolic syndrome X	5.15e-06	0.00143	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—G6PC2—metabolic syndrome X	4.91e-06	0.00137	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NAMPT—metabolic syndrome X	4.81e-06	0.00134	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GCK—metabolic syndrome X	4.78e-06	0.00133	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LIPC—metabolic syndrome X	4.78e-06	0.00133	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOC3—metabolic syndrome X	4.75e-06	0.00132	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	4.67e-06	0.0013	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF2—metabolic syndrome X	4.65e-06	0.0013	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CETP—metabolic syndrome X	4.61e-06	0.00128	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	4.52e-06	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOB—metabolic syndrome X	4.52e-06	0.00126	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL5—metabolic syndrome X	4.41e-06	0.00123	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SCARB1—metabolic syndrome X	4.41e-06	0.00123	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—PLA2G4A—metabolic syndrome X	4.4e-06	0.00123	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LPL—metabolic syndrome X	4.31e-06	0.0012	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SREBF1—metabolic syndrome X	4.28e-06	0.00119	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—FABP4—metabolic syndrome X	4.17e-06	0.00116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—HMGCR—metabolic syndrome X	4.17e-06	0.00116	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT2—metabolic syndrome X	4.17e-06	0.00116	CbGpPWpGaD
Famotidine—SLC22A2—Transmembrane transport of small molecules—ALB—metabolic syndrome X	4.09e-06	0.00114	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	3.96e-06	0.0011	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	3.84e-06	0.00107	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	3.73e-06	0.00104	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ABCA1—metabolic syndrome X	3.71e-06	0.00104	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—SLC2A4—metabolic syndrome X	3.71e-06	0.00104	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AGT—metabolic syndrome X	3.69e-06	0.00103	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	3.66e-06	0.00102	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—LEP—metabolic syndrome X	3.62e-06	0.00101	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOE—metabolic syndrome X	3.62e-06	0.00101	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GOT1—metabolic syndrome X	3.6e-06	0.001	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—GGT1—metabolic syndrome X	3.6e-06	0.001	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—APOA1—metabolic syndrome X	3.58e-06	0.000997	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—G6PD—metabolic syndrome X	3.53e-06	0.000983	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	3.48e-06	0.00097	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	3.44e-06	0.00096	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPA—metabolic syndrome X	3.36e-06	0.000938	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCKR—metabolic syndrome X	3.36e-06	0.000938	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	3.26e-06	0.000909	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.24e-06	0.000902	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IRS1—metabolic syndrome X	3.23e-06	0.0009	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA5—metabolic syndrome X	3.23e-06	0.000899	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.13e-06	0.000874	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—INS—metabolic syndrome X	3.09e-06	0.000861	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	3.07e-06	0.000856	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOB—metabolic syndrome X	3.05e-06	0.000851	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—CCL2—metabolic syndrome X	3.04e-06	0.000848	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	3.04e-06	0.000846	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	3e-06	0.000836	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IGF1—metabolic syndrome X	2.99e-06	0.000833	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PLA2G4A—metabolic syndrome X	2.97e-06	0.000828	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—LPL—metabolic syndrome X	2.91e-06	0.000813	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—SERPINE1—metabolic syndrome X	2.84e-06	0.000791	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—CD36—metabolic syndrome X	2.77e-06	0.000772	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—NOS3—metabolic syndrome X	2.71e-06	0.000755	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	2.69e-06	0.00075	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.67e-06	0.000746	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LIPC—metabolic syndrome X	2.67e-06	0.000745	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GCK—metabolic syndrome X	2.67e-06	0.000745	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOC3—metabolic syndrome X	2.66e-06	0.000741	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CETP—metabolic syndrome X	2.58e-06	0.000719	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARA—metabolic syndrome X	2.57e-06	0.000718	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AGT—metabolic syndrome X	2.49e-06	0.000695	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	2.47e-06	0.000689	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOE—metabolic syndrome X	2.44e-06	0.000681	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—APOA1—metabolic syndrome X	2.41e-06	0.000673	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.4e-06	0.00067	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	2.4e-06	0.000668	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	2.33e-06	0.00065	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT2—metabolic syndrome X	2.33e-06	0.00065	CbGpPWpGaD
Famotidine—HRH2—GPCR downstream signaling—AKT1—metabolic syndrome X	2.32e-06	0.000647	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—IL6—metabolic syndrome X	2.29e-06	0.000637	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PPARG—metabolic syndrome X	2.13e-06	0.000593	CbGpPWpGaD
Famotidine—HRH2—Signaling by GPCR—AKT1—metabolic syndrome X	2.11e-06	0.000588	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.1e-06	0.000587	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—INS—metabolic syndrome X	2.09e-06	0.000582	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	2.08e-06	0.00058	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	2.08e-06	0.00058	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GOT1—metabolic syndrome X	2.01e-06	0.000561	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—GGT1—metabolic syndrome X	2.01e-06	0.000561	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—ALB—metabolic syndrome X	1.91e-06	0.000533	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—NOS3—metabolic syndrome X	1.83e-06	0.00051	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—TGFB1—metabolic syndrome X	1.79e-06	0.0005	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOB—metabolic syndrome X	1.71e-06	0.000476	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—PTGS2—metabolic syndrome X	1.67e-06	0.000467	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	1.66e-06	0.000463	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—LPL—metabolic syndrome X	1.63e-06	0.000455	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—CD36—metabolic syndrome X	1.55e-06	0.000432	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARA—metabolic syndrome X	1.44e-06	0.000402	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AGT—metabolic syndrome X	1.4e-06	0.000389	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOE—metabolic syndrome X	1.37e-06	0.000381	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—APOA1—metabolic syndrome X	1.35e-06	0.000377	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—IL6—metabolic syndrome X	1.35e-06	0.000376	CbGpPWpGaD
Famotidine—HRH2—Signaling Pathways—AKT1—metabolic syndrome X	1.25e-06	0.000347	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PPARG—metabolic syndrome X	1.19e-06	0.000332	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—INS—metabolic syndrome X	1.17e-06	0.000326	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—ALB—metabolic syndrome X	1.07e-06	0.000299	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—NOS3—metabolic syndrome X	1.02e-06	0.000286	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	9.37e-07	0.000261	CbGpPWpGaD
Famotidine—SLC22A2—Metabolism—AKT1—metabolic syndrome X	8.41e-07	0.000235	CbGpPWpGaD
Famotidine—CYP2C19—Metabolism—AKT1—metabolic syndrome X	4.71e-07	0.000131	CbGpPWpGaD
